(a) The hospice admits a patient only on the recommendation of the medical director (or the physician designee, as defined in § 418.3) or the physician member of the hospice interdisciplinary group, in consultation with, or with input from, the patient's attending physician (if any).
(b) In reaching a decision to certify that the patient is terminally ill, the hospice medical director (or the physician designee, as defined in § 418.3) or the physician member of the hospice interdisciplinary group, must consider at least the following information:
(1) Diagnosis of the terminal condition of the patient.
(2) Other health conditions, whether related or unrelated to the terminal condition.
(3) Current clinically relevant information supporting all diagnoses.
[70 FR 70547, Nov. 22, 2005, as amended at 89 FR 64272, Aug. 6, 2024; 90 FR 37431, Aug. 5, 2025]
Notes of Decisions
United States v. Aseracare, Inc., 938 F.3d 1278 (11th Cir. 2019).
“102 (b); 42 C.F.R. § 418.25 (b) (establishing that, “[i]n reaching a decision to certify that the patient is terminally ill, the hospice medical direct must consider at least” the diagnosis of the patient, other health conditions, and “[c]urrent clinically relevant information…”
U.S. ex rel. Kathi Holloway, 960 F.3d 836 (6th Cir. 2020).
“” 42 C.F.R. § 418.25 (b). Submitting a fraudulent certified claim for payment for care provided to a hospice-ineligible patient constitutes a false claim.”
United States of Am. v. Curo Health Servs. Holdings, Inc. (M.D. Tenn. 2022).
“” 42 C.F.R. § 418.25 (a). In making that decision, the medical director must consider “(1) [d]iagnosis of the terminal condition of the patient[;] (2) [o]ther health conditions, whether related or unrelated to the terminal condition[; and] (3) [c]urrent clinically relevant…”
Annotations are extracted automatically from the opinions in the
Syfert caselaw corpus and ranked by authority, recency, and
treatment. Dots show Syfertize treatment of the citing case itself.